ArticleGut2006
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.
Article in Gut, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02937012 (Efficacy and Security of Bezafibrate in Patients With Primary Biliary Cirrhosis Without Biochemical Response to Ursodeoxycholic Acid), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Security of Bezafibrate in Patients With Primary Biliary Cirrhosis Without Biochemical Response to Ursodeoxycholic Acid: A Randomized, Double-blind, Placebo-controlled Trial
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.
- Symptom burden and treatment patterns in primary biliary cholangitis: A systematic review and meta-analysis.Hepatology communications · 2026Pooled it
- Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.Digestive diseases and sciences · 2019Pooled it
- An experimental study on the effect of symptom expectations on mental fatigue and motivation in people with primary biliary cholangitis.Scientific reports · 2025Trial
- Austrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis.Wiener klinische Wochenschrift · 2026Article
- Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders.Pharmaceuticals (Basel, Switzerland) · 2025Review
- [Symptom perception and coping in patients with primary biliary cholangitis: a qualitative study in the context of SOMA.LIV].Psychotherapie, Psychosomatik, medizinische Psychologie · 2025Article
- Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis.Frontiers in medicine · 2024Article
- The influence of muscle performance and fatigue on prognosis in patients with compensated liver disease.BMC gastroenterology · 2023Article
- Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitis.Journal of translational internal medicine · 2023Article
- Is fatigue related to the severity of liver inflammation in patients with chronic liver disease? A cross-sectional study.BMJ open · 2023Article
- Article
- Update on Emerging Treatment Options for Primary Biliary Cholangitis.Hepatic medicine : evidence and research · 2020Review
- Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.PloS one · 2019Article
- Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis.Clinical and translational gastroenterology · 2018Article
- Primary Biliary Cholangitis Alters Functional Connections of the Brain's Deep Gray Matter.Clinical and translational gastroenterology · 2017Article
- Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire.PloS one · 2017Article
- Managing Sleep Disturbances in Cirrhosis.Scientifica · 2016Review
- Recent advances in the development of farnesoid X receptor agonists.Annals of translational medicine · 2015Review
- Article
- Primary biliary cirrhosis and liver transplantation.Intractable & rare diseases research · 2012Review
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsFatigue is the commonest symptom described by patients in most populations with the autoimmune liver disease primary biliary cirrhosis (PBC), and appears to be unrelated to liver disease severity. At present, it is unclear how the fatigue experienced by patients (only characterised to date in cross sectional studies) evolves over time. In this study, we set out to address how fatigue had changed over four years of follow up in a geographically defined cohort of PBC patients who participated in an earlier cross sectional study of fatigue impact.
methodsParticipants in the original 2000 study who were still alive in 2004 were asked to complete the same fatigue assessment tool (fatigue impact score, FIS). In those who had died between 2000 and 2004, medical notes, death certificates, and primary care records were reviewed.
resultsA total of 108 of the original cohort of 136 patients were alive at the time of the follow up study, 99 of whom (92%) participated in the follow up study. With the exception of four patients who underwent transplantation between 2000 and 2004, all of whom showed significant improvement in fatigue severity as assessed by FIS, fatigue severity was unchanged over four years of follow up. Among the 28 patients who died during the follow up period, survival was significantly lower in patients who were fatigued at the 2000 baseline (FIS above the median for the whole PBC population (40/160); log rank test, p = 0.006 v non-fatigued patients at baseline). Increased fatigue severity was independently associated with decreased survival on multivariate analysis. Fatigued PBC subjects were significantly more likely to have suffered a cardiac death than non-fatigued patients.
conclusionsThe fatigue phenotype appears to be highly stable in PBC. The presence of fatigue in PBC is independently associated with a significantly increased risk of death in general, and cardiac death in particular. Factors underpinning fatigue in PBC, and the mechanisms whereby fatigue is associated with increased mortality, warrant further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.